Main Article Content


Apert syndrome (AS) is a craniosynostosis condition
caused by mutations in the Fibroblast Growth Factor Receptor 2(FGFR2) gene. Clinical features include cutaneous and osseous
symmetric syndactily in hands and feet, with variable presentations in
bones, brain, skin and other internal organs.
Methods:Members of two families with an index case of Apert
Syndrome were assessed to describe relevant clinical features and
molecular analysis (sequencing and amplification) of exons 8, 9 and
10 of FGFR2 gen.
Results: Family 1 consists of the mother, the index case and half
-brother who has a cleft lip and palate. In this family we found a
single FGFR2 mutation, S252W, in the sequence of exon 8. Although
mutations were not found in the study of the patient affected with cleft
lip and palate, it is known that these diseases share signaling pathways,
allowing suspected alterations in shared genes. In the patient of family
2, we found a sequence variant T78.501A located near the splicing
site, which could interfere in this process, and consequently with the
protein function

Lilian Torres, Fundación Universitaria de Ciencias de la Salud. Bogota, Colomb

Grupo Ciencias Básicas en Salud CBS.

Guaberto Yesid Hernández Acevedo, Fundación Universitaria de Ciencias de la Salud. Bogota, Colomb

Grupo Ciencias Básicas en Salud CBS.

Alejandro Barrera, Fundación Universitaria de Ciencias de la Salud. Bogota, Colombia

Grupo Ciencias Básicas en Salud CBS.
Torres, L., Hernández Acevedo, G. Y., Barrera, A., Ospina, S., & Prada, R. (2015). Molecular analysis of exons 8, 9 and 10 of the fibroblast growth factor receptor 2 (FGFR2) gene in two families with index cases of Apert Syndrome. Colombia Medica, 46(3), 150–153.

Tiller G. Apert syndrome. Available in: 15 January 2013

Bhatt S, Diaz R, Trainor P. Signals and switches in mammalian neural crest cell differentiation. Cold Spring Harb Perspect Biol. 2013;5(2)pii: a008326

Wilkie AO, Slaney SF, Oldridge M, Poole MD, Ashworth GJ, Hockley AD, et al. Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome. Nat Genet. 1995;9:165–172

O'Neill M. Fibroblast Growth Factor Receptor 2. a Available in: . 18 January 2013

Slaney SF, Oldridge M, Hurst JA, Moriss-Kay GM, Hall CM, Poole MD, et al. Differential effects of FGFR2 mutations on syndactyly and cleft palate in Apert syndrome. Am J Hum Genet. 1996;58:923–932

Riley BM, Mansilla MA, Ma J, Daack-Hirsch S, Maher BS, Raffensperger LM, et al. Impaired FGF signaling contributes to cleft lip and palate. Proc Natl Acad Sci. 2007;104:4512–4517

Ibrahimi OA, Eliseenkova AV, Plotnikov AN, Yu K, Ornitz DM, Mohammadi M. Structural basis for fibroblast growth factor receptor 2 activation in Apert syndrome. Proc Natl Acad Sci. 2001;98:7182–7187

Stanier P, Pauws E. Development of the lip and palateFGF signalling. Front Oral Biol. 2012;16:71–80

Hajihosseini MK, Wilson S, De Moerlooze L, Dickson C. A splicing swich and gain-of-function mutaton inFgfR2-III hemizigotes causes Apert/Pfeiffer syndrome-Like phenotypes. Proc Natl Acad Sci. 2001;98:3855–3860


Download data is not yet available.
Received 2015-01-23
Accepted 2015-09-23
Published 2015-09-30